Drug Channels Archive

Individual mailing archives are available to subscribers only.


Click a link below to view the mailing archive as if it had been sent to you.

2020-07-14 07:19Drug Channels - Walgreens and CVS Top the 28,000 Pharmacies Profiting from the 340B Program. Will the Unregulated Party End?
2020-07-10 07:34Drug Channels - CMS Best Price Proposal and Copay Assistance: How New Rule Could Change the Access Landscape
2020-07-09 09:17Drug Channels - The Top 15 Specialty Pharmacies of 2019: PBMs Stay On Top (rerun)
2020-07-08 08:42Drug Channels - Four Unexpected Ways that the COVID-19 Medicaid Boom Will Affect PBM and Pharmacy Profits (rerun)
2020-07-07 07:45Drug Channels - Pharmacy DIR Fees Hit a Record $9 Billion in 2019—That's 18% of Total Medicare Part D Rebates (rerun)
2020-07-06 07:48Drug Channels - The Top 15 U.S. Pharmacies of 2019: Specialty Drugs Drive the Industry's Evolution (rerun)
2020-06-24 07:46Drug Channels News Roundup, June 2020: CVS's New GPO, CMS on Copay Accumulators, GoodRx Fees, Supermarket Pharmacies, and Merck's Ken Frazier
2020-06-16 07:48Drug Channels - PBMs and Drug Spending in 2019: CVS Health and Express Scripts Outperform Prime Therapeutics
2020-06-12 07:40Drug Channels - The Ripple Effect of Medication Access Barriers—Disruption to Stakeholder Workflows, Damage to Brand Perception, and Detriment to Innovation
2020-06-09 07:47Drug Channels - New HRSA Data: 340B Program Reached $29.9 Billion in 2019; Now Over 8% of Drug Sales
2020-06-03 07:06Drug Channels - Pharmacist Job Market in 2019: Salaries Grew, Hospital-to-Retail Employment Shift Accelerated
2020-06-01 07:52Drug Channels - Visit Asembia's Specialty Pharmacy Summit Virtual Experience

Please enter all required fields Click to hide
Correct invalid entries Click to hide

Subscribe >>